Efectos vasomotores coronarios de la serotonina en pacientes con angina de pecho. Relación con la morfología de la estenosis coronaria
Video Experimental Relacionado
Updated: Jul 27, 2026

12:37
Surgical Placement of Catheters for Long-term Cardiovascular Exercise Testing in Swine
Published on: February 9, 2016
D Tousoulis1, G Davies, E McFadden
1Cardiovascular Research Unit, Royal Postgraduate Medical School, Hammersmith Hospital, London, England.
Circulation
|October 1, 1993
Resumen
La morfología de la estenosis coronaria tiene un impacto significativo en la serotonina.
Área de la Ciencia:
- Medicina Cardiovascular La medicina cardiovascular es una especialidad de la salud.
- Farmacología Farmacología.
- Imágenes médicas de imágenes médicas.
Sus antecedentes:
- Estudios anteriores indicaron que el efecto de la serotonina en la estenosis coronaria varía con el cumplimiento.
- La relación entre la morfología de la estenosis coronaria y la respuesta a la serotonina en pacientes con angina de pecho era previamente desconocida.
Objetivo del estudio:
- Para investigar el impacto de la morfología de la estenosis coronaria en la respuesta del vasoconstrictor a la serotonina.
- Para determinar si las características de la placa influyen en el efecto de la serotonina en pacientes con angina.
Principales métodos:
- Se utilizó una angiografía coronaria cuantitativa computarizada.
- Se administró una infusión intracoronaria de serotonina a 38 estenosis coronarias en 15 pacientes (11 angina estable, 4 variantes de angina).
- Las estenosis se clasificaron por morfología: concéntricas, excéntricas y complicadas.
Principales resultados:
- Las estenosis complicadas mostraron una constricción del 100%, mientras que el 50% de las estenosis concéntricas se contrajeron en >= 20%.
- La magnitud de la constricción fue mayor en las estenosis complicadas (57,69 +/- 7,6%), seguidas por las excéntricas (32,08 +/- 4,1%) y las concéntricas (15,68 +/- 2,8%).
- El contorno irregular de la placa se correlacionó con una mayor respuesta vasoconstrictora a la serotonina en comparación con las lesiones lisas.
Conclusiones:
- La morfología de la placa coronaria, particularmente el contorno irregular, dicta la respuesta del vasoconstrictor a la serotonina.
- La severidad o duración de la estenosis se correlacionó menos con la respuesta a la serotonina que con la morfología de la placa.
- Las variaciones en la actividad de los receptores de serotonina o la respuesta de las células del músculo liso pueden explicar las respuestas diferenciales en la enfermedad de las arterias coronarias.
Videos de Conceptos Relacionados
Antianginal Drugs: Nitrates and β-Blockers
In cardiovascular health, antianginal drugs combat angina pectoris — a condition marked by chest pain owing to diminished blood flow to the heart.
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow. Administered...
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow. Administered...
Antianginal Drugs: Calcium Channel Blockers and Ranolazine
Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
Coronary Artery Disease V: Interprofessional Care
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Angina I: Introduction
Definition and Symptoms: Angina (angina pectoris) is chest pain or discomfort caused by myocardial ischemia, which occurs when the heart muscle receives insufficient oxygen-rich blood. It typically manifests as pressing, squeezing, or crushing sensations in the chest and may radiate to the shoulders, arms, neck, jaw, or back.Primary Cause: In a healthy state, the coronary arteries can dilate (widen) to increase blood flow and meet the increased oxygen demand during physical activity or...
Angina III: Clinical Manifestations and Assessment
Angina manifests as chest pain, tightness, or squeezing discomfort typically located behind the breastbone. It can radiate to the neck, jaw, shoulders, and inner aspects of the upper arms, most commonly the left arm. Patients may experience shortness of breath, fatigue, profuse sweating, dizziness, indigestion, heartburn, palpitations, anxiety, and vomiting as accompanying symptoms. This pain often lasts a few minutes and is triggered by physical exertion, emotional stress, heavy meals, or cold...
Angina IV: Management
IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...

